An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...

Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

As of January 2025, Ozempic's weekly prescriptions were reported at 576,790, while Mounjaro (tirzepatide ... agonist that has shown competitive weight loss percentages in early trials.

Oprah Winfrey is sharing new details on her weight loss in recent years ... have complications from being overweight. Ozempic and Mounjaro are approved to treat Type 2 diabetes.

Whether you’ve been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you’re likely wondering what to eat (and not to eat) while taking the medication. After all ...

They’ll ultimately prescribe the lowest dose that provides the desired effect. The following bupropion dosage chart highlights ... isn’t approved for weight loss, so there’s no dosage ...